{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.\r\n","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.\r\n\r\n"},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"P1M","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"6e103cd0-6e49-4c06-8845-427a81297aad","metadata_created":"2021-07-26T19:41:25.424853","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-10-25T01:50:46.807465","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-26","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Caractéristiques épidémiologiques","cliniques","syndrome inflammatoire","multisystémique","adultes","Table","consultation","scientifique","COVID-19","Ontario","groupe","travail","lignes","directrices","matière","pratique","clinique","médicaments","biologiques","produits","biologiques","argument","faveur","collecte","données","populations","racialisées","Canada","étranger","Nombre","positifs","Populations","racialisées","mortalité","attribuable","incidence","multisystem","inflammatory","MIS-A","maladie","coronavirus","2019","CRP","protéine C-réactive","MIS-C","syndrome","inflammatoire","multisystémique","enfants","NT-proBNP","peptide natriurétique","type B","prohormone","N-terminal","RT-PCR","réaction","chaîne","polymérase","transcription","inverse","SRAS-CoV-2","syndrome","respiratoire","aigu","sévère","coronavirus 2","Traitement","Strongyloides","Ivermectine","chez patients","atteints","maladie","coronavirus","OP","œufs","parasites","USI","unité","soins","intensifs","Recommandations","thérapeutiques","Délais","d’exécution","prévus","analystes","Évaluation","risque","Strongyloides","patients","atteints","sérologiques","Traitement","strongyloïdose","patients","atteints","ivermectine","facteur","nécrose","tumorale","interleukine-1","IL-1","Botulisme","infantile","Canada","1979","2019","morbidité","microbiologie","confirmés","laboratoire","Base","données","congés","patients","BDCP","hospitalière","BDMH","Institut","canadien","information","santé","ICIS","hospitalisations","cas","botulisme","infantile","SCSMDO","Prévention","propagation","variantes","Possibilité","intensification","efforts","dépistage","recherche","contacts","prévenir","nouvelles","éclosions","attribuables","variants","plus","transmissibles","variants préoccupants","Réponse","collectivité","Premières Nations","éclosion","glomérulonéphrite","poststreptococcique","GNPS","L’hépatite C","Intervention","en santé publique","nouvellement","diagnostiqué","d’hépatite C","associé à","une lacune","pratiques de prévention","contrôle des infections","établissement","dentaire","en Ontario","Canada","le virus","l’hépatite C","VHC","contrôle des infections","PCI","virus","acide ribonucléique","ARN","Circonscription sanitaire","du district","d'd'Haliburton","Kawartha","Pine Ridge","voyages en avion","Mesures","protection","voyages aériens","argument","faveur","collecte de données","populations racialisées","au Canada","à l’étranger","Cas hospitalisés","Cas","unités","de soins","intensifs","des hôpitaux","Décès","liés à","COVID","coronavirus","RMTC","révue"],"en":["COVID-19","Science","Advisory","Table","Drugs","Biologics","Clinical","Practice","Guidelines","Working","Group","case","collection","race","data","Canada","abroad","Number","positive","cases","Hospitalized cases","Cases","intensive care units","Deaths","caused","Implementation","preventive measures","Racialized populations","incidence","Racialized populations","mortality","Epidemiologic","clinical characteristics","multisystem","inflammatory syndrome","in adults","MIS-C","coronavirus disease","2019","CRP","C-reactive protein","multisystem","inflammatory syndrome","in children","NT-proBNP","N-terminal pro-hormone","B-type natriuretic peptide","RT-PCR","reverse transcription","polymerase chain reaction","SARS-CoV-2","severe acute","respiratory syndrome","coronavirus 2","Treating Strongyloides","ivermectin in patients","with","ICU","intensive care unit","OAP","ova and parasites","Therapeutic","recommendations","Serologic testing","expected","turn-around-time","Treatment","strongyloidiasis","Committee","Advise","Tropical Medicine","Travel","CATMAT","Assessment","Strongyloides risk","ivermectin","tumour","necrosis factor","TNF","interleukin-1","IL-1","morbidity","microbiology","laboratory","confirmed","cases","infant","botulism","in Canada","1979–2019","British Columbia","Centre for Disease Control","BCCDC","Public Health Laboratory","Discharge Abstract","Database","DAD","Hospital","Morbidity","Database","HMDB","Canadian","Institute","Health","Information","CIHI","data","on hospitalization","infant botulism cases","CNDSS","Botulism","Reference Service","BRS","Preventing","spread variants","testing","tracing efforts","prevent","outbreaks","more transmissible","variants","variants","of concern","VOCs","First Nations","community","development","community-based","public health","response","outbreak","post-streptococcal","glomerulonephritis","Nations","community response","outbreak","post-streptococcal","glomerulonephritis","Post-streptococcal","glomerulonephritis","PSGN","Hepatitis C","public health","response to","newly diagnosed","case of","hepatitis C","associated","with lapse","Infection","Prevention","Control practices","dental setting","Ontario","hepatitis C virus","HCV","Infection Prevention","Control","IPAC","Haliburton","Kawartha","Pine Ridge","District Health Unit","KPRDHU","ribonucleic acid","RNA","air travel","protective measures","COVID","coronavirus","CCDR","journal"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"RMTC : Volume 47-7/8, juillet/août 2021 : Botulisme infantile au Canada, 1979 à 2019","en":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d2c13007-b4a8-4c9a-8ed4-ce823b1471f5","related_relationship":"","name_translated":{"fr":"RMTC : Volume 47-7/8, juillet/août 2021 : Botulisme infantile au Canada, 1979 à 2019","en":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019","language":["en"],"created":"2021-07-26T19:41:25.536372","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021.html","last_modified":null,"position":0,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6943e907-74ee-4d31-b9cb-1b60383571fb","related_relationship":"","name_translated":{"fr":"RMTC : Volume 47-7/8, juillet/août 2021 : Botulisme infantile au Canada, 1979 à 2019","en":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019","language":["fr"],"created":"2021-07-26T19:41:25.536379","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021.html","last_modified":null,"position":1,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c6f121f8-1583-4c52-b481-7bd0fe9ab3af","related_relationship":"","name_translated":{"fr":"Commentaire : Avertissement au sujet des questions de mesure et de méthodologie associées au suivi et à l’évaluation du coronavirus dans l’ensemble des administrations","en":"Commentary: A warning about measurement and methodological issues associated with coronavirus tracking and evaluation across jurisdictions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Commentary: A warning about measurement and methodological issues associated with coronavirus tracking and evaluation across jurisdictions","language":["en"],"created":"2021-07-26T19:41:25.536381","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-tracking-evaluation.html","last_modified":null,"position":2,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c0f120cd-b2ba-4c18-903c-f96eaa5cc4f0","related_relationship":"","name_translated":{"fr":"Commentaire : Avertissement au sujet des questions de mesure et de méthodologie associées au suivi et à l’évaluation du coronavirus dans l’ensemble des administrations","en":"Commentary: A warning about measurement and methodological issues associated with coronavirus tracking and evaluation across jurisdictions"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Commentary: A warning about measurement and methodological issues associated with coronavirus tracking and evaluation across jurisdictions","language":["fr"],"created":"2021-07-26T19:41:25.536383","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/covid-19-suivi-evaluation.html","last_modified":null,"position":3,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"321210ac-1494-422d-9b35-76f08c341e88","related_relationship":"","name_translated":{"fr":"Aperçu : COVID-19 : Un argument en faveur de la collecte de données sur les populations racialisées au Canada et à l’étranger","en":"Overview: COVID-19: A case for the collection of race data in Canada and abroad"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: COVID-19: A case for the collection of race data in Canada and abroad","language":["en"],"created":"2021-07-26T19:41:25.536385","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-race-data-collection-canada.html","last_modified":null,"position":4,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"063b6856-44ad-4393-8765-1a2922e03696","related_relationship":"","name_translated":{"fr":"Aperçu : COVID-19 : Un argument en faveur de la collecte de données sur les populations racialisées au Canada et à l’étranger","en":"Overview: COVID-19: A case for the collection of race data in Canada and abroad"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Overview: COVID-19: A case for the collection of race data in Canada and abroad","language":["fr"],"created":"2021-07-26T19:41:25.536387","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/covid-19-collecte-donnees-race-canada.html","last_modified":null,"position":5,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b57f8962-ff0a-4ac5-81ad-38d9e1faf1b2","related_relationship":"","name_translated":{"fr":"Communication rapide : Caractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique chez les adultes : un examen rapide","en":"Rapid Communication: Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid Communication: Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review","language":["en"],"created":"2021-07-26T19:41:25.536389","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/multisystem-inflammatory-syndrome-adults.html","last_modified":null,"position":6,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"d3e86c7f-c0dc-4611-b499-0e8f323f3d95","related_relationship":"","name_translated":{"fr":"Communication rapide : Caractéristiques épidémiologiques et cliniques du syndrome inflammatoire multisystémique chez les adultes : un examen rapide","en":"Rapid Communication: Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid Communication: Epidemiologic and clinical characteristics of multisystem inflammatory syndrome in adults: a rapid review","language":["fr"],"created":"2021-07-26T19:41:25.536391","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/syndrome-inflammatoire-multisystemique-adultes.html","last_modified":null,"position":7,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","id":"ae4fdebe-6230-4f8f-8de7-2127cc57b1dc","state":"active","name_translated":{"fr":"Communication rapide : Traitement à l’ivermectine pour l’infection à Strongyloides chez les patients atteints de COVID-19","en":"Rapid Communication: Ivermectin treatment for Strongyloides infection in patients with COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid Communication: Ivermectin treatment for Strongyloides infection in patients with COVID-19","language":["en"],"created":"2021-07-26T19:41:25.536393","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-treating-strongyloides-ivermectin-patients.html","last_modified":null,"position":8,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"6fb9326d-3481-4217-9808-1b26c415357a","related_relationship":"","name_translated":{"fr":"Communication rapide : Traitement à l’ivermectine pour l’infection à Strongyloides chez les patients atteints de COVID-19","en":"Rapid Communication: Ivermectin treatment for Strongyloides infection in patients with COVID-19"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Rapid Communication: Ivermectin treatment for Strongyloides infection in patients with COVID-19","language":["fr"],"created":"2021-07-26T19:41:25.536394","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/covid-19-traitement-strongyloides-ivermectine-patients.html","last_modified":null,"position":9,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"61145b5c-f5fe-4b2e-a32e-6a182e87a605","related_relationship":"","name_translated":{"fr":"Surveillance : Un résumé de la surveillance, de la morbidité et de la microbiologie des cas confirmés en laboratoire de botulisme infantile au Canada, de 1979 à 2019","en":"Surveillance: A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019","language":["en"],"created":"2021-07-26T19:41:25.536396","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/infant-botulism-canada-1979-2019.html","last_modified":null,"position":10,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"0ec27378-7611-4ce8-b20d-f6389b7cb003","related_relationship":"","name_translated":{"fr":"Surveillance : Un résumé de la surveillance, de la morbidité et de la microbiologie des cas confirmés en laboratoire de botulisme infantile au Canada, de 1979 à 2019","en":"Surveillance: A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Surveillance: A summary of surveillance, morbidity and microbiology of laboratory-confirmed cases of infant botulism in Canada, 1979–2019","language":["fr"],"created":"2021-07-26T19:41:25.536398","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/botulisme-infantile-canada-1979-2019.html","last_modified":null,"position":11,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b034e057-d346-4733-af54-771d9c0d8d5f","related_relationship":"","name_translated":{"fr":"Science de l’application des connaissances : Possibilité d’intensification des efforts de dépistage et de recherche de contacts pour prévenir les nouvelles éclosions de COVID-19 attribuables à des variants plus transmissibles","en":"Implementation Science: A window of opportunity for intensifying testing and tracing efforts to prevent new COVID-19 outbreaks due to more transmissible variants"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Implementation Science: A window of opportunity for intensifying testing and tracing efforts to prevent new COVID-19 outbreaks due to more transmissible variants","language":["en"],"created":"2021-07-26T19:41:25.536400","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-variants.html","last_modified":null,"position":12,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"3126838f-e05d-4a07-a028-f313ed1a528a","related_relationship":"","name_translated":{"fr":"Science de l’application des connaissances : Possibilité d’intensification des efforts de dépistage et de recherche de contacts pour prévenir les nouvelles éclosions de COVID-19 attribuables à des variants plus transmissibles","en":"Implementation Science: A window of opportunity for intensifying testing and tracing efforts to prevent new COVID-19 outbreaks due to more transmissible variants"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Implementation Science: A window of opportunity for intensifying testing and tracing efforts to prevent new COVID-19 outbreaks due to more transmissible variants","language":["fr"],"created":"2021-07-26T19:41:25.536402","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/covid-19-variantes.html","last_modified":null,"position":13,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"477fa73e-6b41-46d3-bbf8-62320c7ef531","related_relationship":"","name_translated":{"fr":"Éclosion : L’élaboration d’une réponse de santé publique communautaire à une éclosion de glomérulonéphrite poststreptococcique dans une collectivité des Premières Nations","en":"Outbreak: The development of a community-based public health response to an outbreak of post-streptococcal glomerulonephritis in a First Nations community"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: The development of a community-based public health response to an outbreak of post-streptococcal glomerulonephritis in a First Nations community","language":["en"],"created":"2021-07-26T19:41:25.536404","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/first-nations-response-outbreak-post-streptococcal-glomerulonephritis.html","last_modified":null,"position":14,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"61034156-a8b4-4802-a4a0-a1952707607a","related_relationship":"","name_translated":{"fr":"Éclosion : L’élaboration d’une réponse de santé publique communautaire à une éclosion de glomérulonéphrite poststreptococcique dans une collectivité des Premières Nations","en":"Outbreak: The development of a community-based public health response to an outbreak of post-streptococcal glomerulonephritis in a First Nations community"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: The development of a community-based public health response to an outbreak of post-streptococcal glomerulonephritis in a First Nations community","language":["fr"],"created":"2021-07-26T19:41:25.536405","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/reponse-premieres-nations-eclosion-glomerulonephrite-poststreptococcique.html","last_modified":null,"position":15,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"dd7deb0d-080c-4d04-9ca2-822b1b29a1fa","related_relationship":"","name_translated":{"fr":"Éclosion : Intervention en santé publique à un cas nouvellement diagnostiqué d’hépatite C associé à une lacune dans les pratiques de prévention et de contrôle des infections dans un établissement dentaire en Ontario, Canada","en":"Outbreak: A public health response to a newly diagnosed case of hepatitis C associated with lapse in Infection Prevention and Control practices in a dental setting in Ontario, Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: A public health response to a newly diagnosed case of hepatitis C associated with lapse in Infection Prevention and Control practices in a dental setting in Ontario, Canada","language":["en"],"created":"2021-07-26T19:41:25.536407","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/hepatitis-c-public-health.html","last_modified":null,"position":16,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"61a49560-deeb-45d3-b8f4-25b7cbeb8a2e","related_relationship":"","name_translated":{"fr":"Éclosion : Intervention en santé publique à un cas nouvellement diagnostiqué d’hépatite C associé à une lacune dans les pratiques de prévention et de contrôle des infections dans un établissement dentaire en Ontario, Canada","en":"Outbreak: A public health response to a newly diagnosed case of hepatitis C associated with lapse in Infection Prevention and Control practices in a dental setting in Ontario, Canada"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Outbreak: A public health response to a newly diagnosed case of hepatitis C associated with lapse in Infection Prevention and Control practices in a dental setting in Ontario, Canada","language":["fr"],"created":"2021-07-26T19:41:25.536409","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/hepatite-c-sante-publique.html","last_modified":null,"position":17,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"627936d1-2d96-465e-9fbb-f8aa0c8d19ce","related_relationship":"","name_translated":{"fr":"COVID en bref: Mesures de protection et voyages aériens dans le cadre de la COVID-19","en":"Covid Brief: COVID-19, protective measures and air travel"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Covid Brief: COVID-19, protective measures and air travel","language":["en"],"created":"2021-07-26T19:41:25.536411","url":"http://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-7-8-july-august-2021/covid-19-air-travel.html","last_modified":null,"position":18,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"6e103cd0-6e49-4c06-8845-427a81297aad","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"c9900ec2-ac04-4ac4-b14e-85c2c912117a","related_relationship":"","name_translated":{"fr":"COVID en bref: Mesures de protection et voyages aériens dans le cadre de la COVID-19","en":"Covid Brief: COVID-19, protective measures and air travel"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Covid Brief: COVID-19, protective measures and air travel","language":["fr"],"created":"2021-07-26T19:41:25.536413","url":"http://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2021-47/numero-7-8-juillet-aout-2021/covid-19-voyages-avion.html","last_modified":null,"position":19,"revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091","resource_type":"website"}],"place_of_publication":[],"num_resources":20,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2021-07-08 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"6e103cd0-6e49-4c06-8845-427a81297aad","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases.\r\n\r\n","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR Vol. 47 No. 7/8, July/August 2021: Infant Botulism in Canada, 1979–2019","revision_id":"752f6f0a-ab0e-4963-9cfb-159212ba1091"}